Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

canview

  • Home
  •  
  • canview



  • Most Read
  • Latest Comments
  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • News

    Vape imports banned, Vitura introduces nicotine vaping products to tap new market

    In a bid to crack down on excessive vaping among the Aussie youth, the Australian government decided to nip the problem in the bud. From January 1, 2024, the Therapeutic Goods Administration (TGA) declared that disposable vapes can’t be imported to Australia, regardless of nicotine or therapeutic claims. Plus, come March 1, 2024, importing all

    Read More
    Public
  • Vitura declares dividend for the second time amid growing cannabis profits
    • News

    Vitura declares dividend for the second time amid growing cannabis profits

    Once again, medical cannabis producer Vitura Health (ASX: VIT) has become the only ASX-listed company operating in the medicinal cannabis space to both generate a profit and declare a dividend since its ASX initiation in 2019. The Company will pay a dividend to shareholders in respect of FY23. The Dividend, which will be paid at

    Read More
    Public
  • Cronos shares slides 20% as company flags large holding set to come out of escrow
    • News

    Cronos shares slides 20% as company flags large holding set to come out of escrow

    Are investors panic selling their shares at medicinal cannabis company Cronos Australia (ASX: CAU)? With 73.4% of the Company’s shares to be released from voluntary escrow soon, it’s the only explanation Cronos could give to the ASX to explain the irregular trading activity.  Cronos, who became Australia’s first ever ASX-listed cannabis company to pay out

    Read More
    Public
  • Cronos all set to launch new version of app to sell cannabis
    • News

    Cronos all set to launch new version of app to sell cannabis

    Cannabis consumers rejoice, medicinal cannabis provider Cronos Australia (ASX:CAU) is very close to finally releasing its Canview platform to make the procurement of the drug an easy affair. The roll-out is happening across stages with the first one comprising a number of order fulfilment upgrades, process improvements and other efficiencies. It was deployed internally within

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.